LivaNova to Host Audio Webcast of Inaugural Investor Day | Business Wire

LONDON–()–LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a

market-leading medical technology company, today announced it will host

an <a rel="wpi" target="_blank" title="" href="">audio webcast</a> of its inaugural investor day in New York on Thursday,

Sept. 14.

</p>

<p style="text-align: center"> of LivaNova’s website. Pre-event registration is

required. Listeners should log on approximately 10 minutes in advance to

How Advertising Strategies Work For Business Growth

The difference between successful business owners enjoying business growth and entrepreneurs barely able to survive in an increasingly crowded marketplace is having in place a clear, result-oriented advertising strategy. Many Malaysian business owners struggle with advertising but partnering with a local firm offering services for advertising in Malaysia can help them develop successful strategies with limited resources.

ensure proper setup to receive the audio webcast, which will be in a

listen-only mode. A replay will be available on the LivaNova website

approximately 24 hours after the live presentation for 90 days after the

event.

About LivaNova

LivaNova PLC is a global medical technology company built on nearly five

decades of experience and a relentless commitment to improve the lives

of patients around the world. LivaNova’s advanced technologies and

breakthrough treatments provide meaningful solutions for the benefit of

patients, healthcare professionals and healthcare systems. Headquartered

in London and with a presence in more than 100 countries worldwide, the

company employs more than 4,500 employees. LivaNova operates as three

business franchises: Cardiac Surgery, Neuromodulation and Cardiac Rhythm

Management, with operating headquarters in Mirandola (Italy),

Houston (U.S.A.) and Clamart (France), respectively.

For more information, please visit .

Safe Harbor Statement

Any forward-looking statements are subject to risks and uncertainties

such as those described in LivaNova’s periodic reports on file with the

Securities and Exchange Commission. Actual results may differ materially

from anticipated results.